Type 1 and Type 2 cytokines: from basic science to fungal infections

被引:0
作者
Murphy, JW [1 ]
Bistoni, F
Deepe, GS
Blackstock, RA
Buchanan, K
Ashman, RB
Romani, L
Mencacci, A
Cenci, E
D'Ostiani, CF
Del Sero, G
Calich, VLG
Kashino, SS
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73190 USA
[2] Univ Perugia, I-06100 Perugia, Italy
[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[4] Univ Western Australia, Nedlands, WA 6009, Australia
[5] Univ Sao Paulo, Sao Paulo, Brazil
关键词
CMI; cytokines; H-capsulatum; Candida albicans; Cryptococcus neoformans; Paracoccidioides brasiliensis;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
At the present time, it is clear that Th1 responses afford protection against the fungi; however, the development, maintenance and function of the protective immune responses are complex mechanisms and are influenced by multiple factors. The route of infection has been shown to affect initial cytokine production and, consequently, the induction of protective Th1 responses. The ability of different isolates of the same fungal agent to induce and sustain a protective response has also been emphasized. Protective immune responses have been shown to vary in genetically different mouse strains after infection. In addition, these protective responses, such as cellular influx and cytokine production, also vary within the same animal depending on the tissue infected. The functional dominance of certain cytokines over others in influencing development and maintenance of protective responses has been discussed. Certain cytokines may act differently in hosts lacking important components of their innate or immune repertoire. It is evident from these presentations that a more comprehensive understanding of the protective mechanisms against different fungal agents is emerging. However, there is still much to learn before cytokine modulatory therapy can be used effectively without risk in the human host.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 40 条
  • [11] CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P585
  • [12] T-HELPER CELL-TYPE-1 (TH1)-LIKE AND TH2-LIKE RESPONSES ARE PRESENT IN MICE WITH GASTRIC CANDIDIASIS BUT PROTECTIVE IMMUNITY IS ASSOCIATED WITH TH1 DEVELOPMENT
    CENCI, E
    MENCACCI, A
    SPACCAPELO, R
    TONNETTI, L
    MOSCI, P
    ENSSLE, KH
    PUCCETTI, P
    ROMANI, L
    BISTONI, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) : 1279 - 1288
  • [13] Crowle A J, 1975, Adv Immunol, V20, P197, DOI 10.1016/S0065-2776(08)60209-6
  • [14] HETEROGENEOUS ACTIVITY OF IMMATURE AND MATURE CELLS OF THE MURINE MONOCYTE-MACROPHAGE LINEAGE DERIVED FROM DIFFERENT ANATOMICAL DISTRICTS AGAINST YEAST-PHASE CANDIDA-ALBICANS
    DECKER, T
    LOHMANNMATTHES, ML
    BACCARINI, M
    [J]. INFECTION AND IMMUNITY, 1986, 54 (02) : 477 - 486
  • [15] TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1
    DINARELLO, CA
    CANNON, JG
    WOLFF, SM
    BERNHEIM, HA
    BEUTLER, B
    CERAMI, A
    FIGARI, IS
    PALLADINO, MA
    OCONNOR, JV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) : 1433 - 1450
  • [16] MARQUIS G, 1988, BRIT J EXP PATHOL, V69, P651
  • [17] CD4(+) T-helper-cell responses in mice with low-level Candida albicans infection
    Mencacci, A
    Spaccapelo, R
    DelSero, G
    Enssle, KH
    Cassone, A
    Bistoni, F
    Romani, L
    [J]. INFECTION AND IMMUNITY, 1996, 64 (12) : 4907 - 4914
  • [18] MENCACCI A, 1995, J MYCOL MED, V5, P25
  • [20] MURPHY JW, 1994, J MED VET MYCOL, V32, P203